Tag Archives: cetuximab

Biological therapy and other novel therapies in early-stage disease: are they appropriate?

Grothey A. Department of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. grothey.axel@mayo.edu For nearly two decades, adjuvant chemotherapy has been the standard of care in patients with early-stage colon cancer at high risk of recurrence. Until … Continue reading

Posted in Cancer, Tratamiento coadyuvante | Tagged , , , , , | Leave a comment

Cetuximab en el tratamiento de cancer colo-rectal

Background Cetuximab, an IgG1 chimeric monoclonal antibody against epidermal growth factor receptor (EGFR), has activity against colorectal cancers that express EGFR. Methods From December 2003 to August 2005, 572 patients who had colorectal cancer expressing immunohistochemically detectable EGFR and who … Continue reading

Posted in Cancer, Medicamentos | Tagged , , , , , | Leave a comment